Globant S.A. (GLOB)
Globant S.A., together with its subsidiaries, provides technology services in the United States, rest of North America, Latin America, Europe, and internationally. The company offers Digital Studio, which integrates artificial intelligence into the software development; GUT Studio, which allows clients to better connect brands; and Enterprise Studio, which leverages technology for streamlined operations and productivity. It also provides AI Industry Studios for the financial services; media, entertainment, sports, and leisure; healthcare and life sciences; CPG, retail, and automotive; gaming and EdTech; airlines; energy, oil, and gas; and high tech and professional services sectors. In addition, the company offers AI Pods, a subscription-based delivery model for AI-powered services; Globant Enterprise AI, an agentic innovation platform; Corporate Hub, which grounds intelligence in how the organization operates; AI Hub, which connects and governs foundation and custom models, continuous evaluation, and optimization; and Agents Hub, which enables autonomous action through the creation and coordination of agents and agentic workflows. Further, it provides GeneXus for enterprise systems evolution; Globant CODA for software development; Navigate Digital Twin for process optimization; Navigate Service Assist for support; and Fusion, for marketing, communications, and advertising, as well as StarMeUp, an employee engagement and talent experience platform; and DaXia, an embedded finance accelerator platform. Globant S.A. has a strategic collaboration with Pharma Mar, S.A. for cancer drug discovery through artificial intelligence; and Viability and Cascadience LLC to launch AI-powered platform for students with disabilities. The company was formerly known as IT Outsourcing S.L. and changed its name to Globant S.A. in December 2012. Globant S.A. was founded in 2003 and is based in Luxembourg, Luxembourg.
- Symbol
- GLOB
- Exchange
- NYSE
- Sector
- Technology
- Industry
- Information Technology Services
- Market cap
- $1.53B
- 52 week range
- 27.56 - 72.1
Valuation
- Share price
- $34.45 (close of 2026-09-23)
- P/E (TTM)
- 15.03x
- Price to book
- 0.71x
- Price to free cash flow
- 5.44x
- Enterprise value
- $1.76B
- Book value per share
- $49.31
Price performance
| Period | Change |
|---|
| 1 day | -3.88% |
| 5 days | -14.09% |
| 1 month | -13.05% |
| 3 months | +17.66% |
| 6 months | -23.19% |
| Year to date | -47.30% |
| 1 year | -39.27% |
| 3 years | -82.75% |
| 5 years | -89.55% |
| 10 years | -17.74% |
| All time | +206.22% |
Profitability and growth
- Return on equity
- 4.76%
- Return on invested capital
- 5.71%
- Return on assets
- 3.10%
- Return on capital employed
- 6.27%
- Gross margin
- 35.00%
- Net margin
- 4.19%
- EBITDA margin
- 7.00%
- Revenue growth
- 1.62%
- Net income growth
- -37.90%
- Free cash flow growth
- 27.58%
Cash flow and balance sheet
- Free cash flow yield (TTM)
- 18.37%
- Current ratio
- 1.64x
- Net debt to EBITDA
- 0.63x
Latest reported year
- Period end
- 2025-12-31
- Fiscal year
- 2025
- Revenue
- $2.45B
- Cost of revenue
- $1.60B
- Gross profit
- $859.29M
- EBITDA
- $171.73M
- Net income
- $102.92M
- Earnings per share
- $2.33
- Interest expense
- $40.61M
- Shares outstanding
- 44.23M
Income statement by year
| Period end | Revenue | Gross profit | Net income | EPS |
|---|
| 2025-12-31 | $2.45B | $859.29M | $102.92M | $2.33 |
| 2024-12-31 | $2.42B | $863.37M | $165.73M | $3.82 |
| 2023-12-31 | $2.10B | $755.76M | $158.54M | $3.72 |
| 2022-12-31 | $1.78B | $669.39M | $148.89M | $3.55 |
| 2021-12-31 | $1.30B | $494.99M | $96.06M | $2.35 |
| 2020-12-31 | $814.14M | $304.33M | $54.22M | $1.41 |
| 2019-12-31 | $659.33M | $254.16M | $54.02M | $1.48 |
| 2018-12-31 | $522.31M | $203.76M | $51.68M | $1.45 |
| 2017-12-31 | $413.44M | $150.27M | $30.54M | $0.87 |
| 2016-12-31 | $322.86M | $131.46M | $35.88M | $1.04 |
Margins and returns by year
| Period end | Gross margin | Net margin | Return on equity | Return on capital |
|---|
| 2025-12-31 | 35.00% | 4.19% | 4.76% | 5.71% |
| 2024-12-31 | 35.74% | 6.86% | 8.15% | 7.99% |
| 2023-12-31 | 36.06% | 7.56% | 8.83% | 9.03% |
| 2022-12-31 | 37.60% | 8.36% | 9.57% | 11.64% |
| 2021-12-31 | 38.16% | 7.41% | 7.34% | 11.40% |
| 2020-12-31 | 37.38% | 6.66% | 6.16% | 8.64% |
| 2019-12-31 | 38.55% | 8.19% | 12.31% | 13.48% |
| 2018-12-31 | 39.01% | 9.89% | 15.29% | 19.56% |
| 2017-12-31 | 36.35% | 7.39% | 11.60% | 11.90% |
| 2016-12-31 | 40.72% | 11.11% | 17.20% | 22.30% |
Cash and debt by year
| Period end | Cash | Debt |
|---|
| 2025-12-31 | $243.74M | $347.04M |
| 2024-12-31 | $142.09M | $290.94M |
| 2023-12-31 | $307.22M | $2.19M |
| 2022-12-31 | $292.46M | $861.00K |
| 2021-12-31 | $427.80M | $1.94M |
| 2020-12-31 | $278.94M | $25.06M |
| 2019-12-31 | $62.72M | $50.19M |
| 2018-12-31 | $77.61M | - |
| 2017-12-31 | $52.52M | - |
| 2016-12-31 | $50.53M | - |
Free cash flow by year
| Period end | Free cash flow | Stock-based compensation |
|---|
| 2025-12-31 | $281.95M | $75.68M |
| 2024-12-31 | $220.99M | $81.80M |
| 2023-12-31 | $273.41M | $72.94M |
| 2022-12-31 | $150.46M | $60.25M |
| 2021-12-31 | $136.21M | $37.03M |
| 2020-12-31 | $70.58M | $22.42M |
| 2019-12-31 | $59.36M | $15.36M |
| 2018-12-31 | $48.03M | $10.55M |
| 2017-12-31 | $23.38M | $12.87M |
| 2016-12-31 | $13.82M | $3.62M |
Investor relations
Next earnings report
- Next confirmed report
- 2026-11-12
- Consensus EPS estimate
- $1.13
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|
| 2026-08-13 | Jun/2026 | $1.16 |
| 2026-05-14 | - | - |
| 2026-02-26 | - | - |
| 2025-11-13 | - | - |
| 2025-08-14 | - | - |
| 2025-05-15 | - | - |
| 2025-02-20 | - | - |
| 2024-11-14 | - | - |
Filings and sources
- Company website
- globant.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
International Business Machines Corp (IBM) · Accenture plc (ACN) · Cognizant Technology Solutions Corp (CTSH) · Fiserv Inc (FISV) · CDW Corp (CDW) · Leidos Holdings, Inc. (LDOS) · Gartner Inc (IT) · Jack Henry & Associates Inc (JKHY)
All Technology companies
Understanding these figures
Price-to-earnings ratio · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades